Submitted:
15 August 2024
Posted:
16 August 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction:
2. Method:
3. Results
4. Discussion:
5. Conclusion:
References
- R. W. Peeling, D. L. Heymann, Y.-Y. Teo and P. J. Garcia, “Diagnostics for COVID-19: moving from pandemic response to control,” The Lancet (British edition), vol. 399, no. 10326, 2022. [CrossRef]
- C. G. McAloon, D. Dahly, C. Walsh, P. Wall, B. Smyth, S. J. More and C. Teljeur, “Potential Application of SARS-CoV-2 Rapid Antigen Diagnostic Tests for the Detection of Infectious Individuals Attending Mass Gatherings – A Simulation Study,” Frontiers in Epidemiology, vol. 2, 2022. [CrossRef]
- R. W. Peeling, P. L. Olliaro, D. I. Boeras and N. Fongwen, “Scaling up COVID-19 rapid antigen tests: promises and challenges,” The Lancet infectious diseases, vol. 21, no. 9, 2021. [CrossRef]
- C. Wertenauer, G. Brenner Michael, A. Dressel, C. Pfeifer, U. Hauser, E. Wieland, C. Mayer, C. Mutschmann, M. Roskos, H.-J. Wertenauer, A. P. Moissl, S. Lorkowski and W. März, “Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study,” Frontiers in medicine, vol. 9, 3/2022. [CrossRef]
- S. Pondaven-Letourmy, F. Alvin, Y. Boumghit and F. Simon, “How to perform a nasopharyngeal swab in adults and children in the COVID-19 era,” European annals of otorhinolaryngology, head and neck diseases, vol. 137, no. 4, 9/ 2020. [CrossRef]
- O. Filchakova, D. Dossym, A. Ilyas, T. Kuanysheva, A. Abdizhamil and R. Bukasov, “Review of COVID-19 testing and diagnostic methods,” Talanta (Oxford), vol. 244, 07/ 2022. [CrossRef]
- J.-W. Xie, Y. He, Y.-W. Zheng, M. Wang, Y. Lin and L.-R. Lin, “Diagnostic accuracy of rapid antigen test for SARS-CoV-2: A systematic review and meta-analysis of 166,943 suspected COVID-19 patients,” Microbiological research, vol. 265, 12/2022. [CrossRef]
- J. P. Skittrall, M. Wilson, A. A. Smielewska, S. Parmar, M. D. Fortune, D. Sparkes, M. D. Curran, H. Zhang and H. Jalal, “Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting,” Clinical microbiology and infection, vol. 27, no. 3, 03/2021. [CrossRef]
- M. Saidani, H. Kim and J. Kim, “Designing optimal COVID-19 testing stations locally: A discrete event simulation model applied on a university campus,” PloS one,, vol. 16, no. 6, 06/2021. [CrossRef]
- R. Kumar, Modeling and Simulation Concepts, India : Laxmi Publications Private Limited, 12/2020.
- L. V. Green, Patient Flow: Reducing Delay in Healthcare Delivery, New York : Springer , 2006.
- J. S. Smith and D. T. Sturrock, Simio and Simulation: Modeling, Analysis, Applications, Sewickley, Pennsylvania.: Simio LLC, 2021.
- J. D. Little and S. C. Graves, Building Intuition: Insights from Basic Operations Management Models and Principles, Massachusetts: Springer , 2008.
- J. F. Shortle, J. M. Thompson, D. Gross and C. M. Harris, Fundamentals of Queueing Theory, 4th ed., Hoboken, NJ, USA: Wiley, 2018.
- A. Turki and E. Raml, “Enhancing Pediatric Adnexal Torsion Diagnosis: Prediction Method Utilizing Machine Learning Techniques,” Children (Basel), vol. 10, no. 10, 09/2023. [CrossRef]
- Abbott, “COVID-19 Ag Rapid Test Device,” 2021. [Online]. Available: https://dam.abbott.com/en-gb/panbio/120007883-v1-Panbio-COVID-19-Ag-Nasal-AsymptomaticSe.pdf. [Accessed 05 2024].
- “Autodesk Revit: BIM software to design and make anything,” Autodesk , [Online]. Available: https://www.autodesk.com/products/revit/overview?term=1-YEAR&tab=subscription. [Accessed May 2024].
- “Google Sheet,” Google LLC, [Online]. Available: https://docs.google.com/spreadsheets/u/0/?usp=sheets_ald. [Accessed May 2025].
- Python, [Online]. Available: https://www.python.org/psf-landing/. [Accessed May 2024].
- I. I. Gerontidis and V. V. Kalashnikov, Mathematical Methods in Queuing Theory., vol. 44, 1995. [CrossRef]
- A. M. Haghighi and D. Mishev, Difference and Differential Equations with Applications in Queueing Theory, John Wiley & Sons, Inc, 2013.
- J. L. Wiler, E. Bolandifar, R. T. Griffey, R. F. Poirier and T. Olsen, An emergency department patient flow model based on queueing theory principles, vol. 20, 2013. [CrossRef]
- D. S. Mouliou, The Deceptive COVID-19: Lessons from Common Molecular Diagnostics and a Novel Plan for the Prevention of the Next Pandemic, vol. 11, 2023. [CrossRef]
- N. Health, “Public Health – NSW COVID-19 Response,” April 2023. [Online]. Available: https://www.health.nsw.gov.au/Infectious/covid-19/evidence-hub/Publications/phr-report.pdf. [Accessed May 2024].
- “Overview of Testing for SARS-CoV-2, the virus that causes COVID-19,” CDC, March 2024. [Online]. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html. [Accessed May 2024].
- N. Castelletti and e. al, “The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases,” Virology , vol. 569, 2022.
- M. Alqahtani, A. Abdulrahman, F. Mustafa, A. I. Alawadhi, B. Alalawi and S. I. Mallah, “Evaluation of Rapid Antigen Tests Using Nasal Samples to Diagnose SARS-CoV-2 in Symptomatic Patients,” Frontiers in public health, vol. 9, 2022.
- K. A. Walsh, N. Broderick, S. Ahern, C. G. Fawsitt, K. M. O’Brien, M. Carrigan, P. Harrington, M. O’Neill, S. M. Smith, S. Spillane, C. Teljeur and M. Ryan, “Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS-CoV-2: A rapid review,” Reviews in medical virology, vol. 32, no. 5, 9/2022.
- A. Khan, Y. Alsofayan, A. Alahmari, J. Alowais, A. Algwizani, H. Alserehi, A. Assiri and H. Jokhdar, “COVID-19 in Saudi Arabia: the national health response,” Eastern Mediterranean health journal, vol. 27, no. 11, 12/2021. [CrossRef]





| Stage | Process | U-Shape | Stright-Line | ||||
|---|---|---|---|---|---|---|---|
| Mean Time (second) | Standard Deviation (second) |
95% CI (second) |
Mean Time (second) | Standard Deviation (second) |
95% CI (second) |
||
| Stage 1 | Que Number Collecting | 7.8 | 2.0 | 7.62 to 7.98 | 6.8 | 2.2 | 6.61 to 6.99 |
| Stage 2 | Registration | 21.9 | 3.3 | 21.61 to 22.19 | 18.6 | 3.1 | 18.33 to 18.87 |
| Stage 3 | Sample Collection | 21.1 | 5.4 | 20.63 to 21.57 | 16.5 | 4.6 | 16.10 to 16.90 |
| Stage 4 | Sample Mixing | 31.4 | 15.7 | 30.02 to 32.78 | 29.8 | 8.4 | 29.06 to 30.54 |
| Stage 5 | Result | 46.1 | 5.1 | 45.65 to 46.55 | 62.6 | 14.8 | 61.30 to 63.90 |
| Average Total Time | 114.2 seconds | 122.7 seconds | |||||
| Total Time Standard Deviation | 17.8 Seconds | 17.6 Seconds | |||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).